177Lu-Edotreotide
Isotopen Technologien Munchen
[]
thank you to , of , for stopping by to speak with us about the phase iii randomized controlled compose trial and gastroenteropancreatic neuroendocrine tumors at #gi23. visit our site to read more: #oncology 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.